 When investigated further, current MDA-MB-435 appeared to be derived from the same individual as cell line M14.An examination of clones made clear that the mixup with M14 happened very early in the history of MDA-MB-435, before establishment in the Developmental Therapeutics Program.NCI/ADR-RES, originally classified as breast cancer cell line, was identified as being an ovarian tumor cell line.